Prop. 14 will build tomorrow’s regenerative medicine leaders. Vote yes
In a recent clinical trial for lymphoma, immune cell therapy completely cleared cancer in 62% of patients —some were on their fifth treatment course. For those patients, the results were a miracle. But it could be so much more. Consider when immune cell therapy is the first treatment. Imagine the lives saved — the patients